Braveheart Bio (BRVE) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 8 31 sessions, August 6, 2026 to September 18, 2026
- Largest daily move
- +10% close of September 8, 2026
Company Description
Braveheart Bio (NASDAQ: BRVE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.6B.
BRVE has gained 9.2% over the past month. The last closing price was $29.20.
This page collects what Stock Titan holds for BRVE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Braveheart Bio (BRVE) closed at $29.20 on September 18, 2026. Over the past month, the price has gained 9.2%.
BRVE Metrics & Rankings
Price returns through September 18, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Braveheart Bio has 5 recent news articles, with the latest published 4 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, IPO, offering. View all BRVE news →
SEC Filings
Braveheart Bio has filed 10 recent SEC filings, including 3 Form 4, 2 Form SCHEDULE 13D, 1 Form 3, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on September 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BRVE SEC filings →
Insider Radar
Insider buying activity at Braveheart Bio over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
NOBLEHEART trial start
LIONHEART interim results
Braveheart Bio has 2 upcoming scheduled events. The next event, "NOBLEHEART trial start", is scheduled for January 1, 2027 (in 102 days). Investors can track these dates to stay informed about potential catalysts that may affect the BRVE stock price.
Short Interest History
Short interest in Braveheart Bio (BRVE) currently stands at 1.4 million shares, up 64.8% from the previous reporting period, representing 5.5% of the float. Since August 2026, short interest has increased by 64.8%. The 5.6 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Braveheart Bio (BRVE) currently stands at 5.6 days, up 330% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 330% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.3 to 5.6 days.
BRVE Company Profile & Sector Positioning
Braveheart Bio (BRVE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.